Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,658Revenue $M778Net Margin (%)18.4Z-Score18.5
Enterprise Value $M2,499EPS $2.3Operating Margin %29.2F-Score4
P/E(ttm))20.5Cash Flow Per Share $1.4Pre-tax Margin (%)29.5Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %0Quick Ratio4.6Cash flow > EarningsN
Price/Sales3.75-y EBITDA Growth Rate %26.5Current Ratio5.0Lower Leverage y-yY
Price/Cash Flow19.2y-y EBITDA Growth Rate %-6.7ROA % (ttm)17.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)19.4Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M73.0ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with MYGN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYGNAndreas Halvorsen 2014-09-30 Sold Out -0.23%$35.44 - $40.41
($37.28)
$ 36.42-2%Sold Out0
MYGNJoel Greenblatt 2014-09-30 Reduce-0.12%$35.44 - $40.41
($37.28)
$ 36.42-2%Reduce -22.18%869,531
MYGNJohn Burbank 2014-09-30 Sold Out -0.01%$35.44 - $40.41
($37.28)
$ 36.42-2%Sold Out0
MYGNAndreas Halvorsen 2014-06-30 Buy 0.23%$33.1 - $42.21
($37.18)
$ 36.42-2%New holding, 1330294 sh.1,330,294
MYGNJohn Burbank 2014-06-30 Buy 0.01%$33.1 - $42.21
($37.18)
$ 36.42-2%New holding, 16676 sh.16,676
MYGNRichard Snow 2014-06-30 Reduce-0.96%$33.1 - $42.21
($37.18)
$ 36.42-2%Reduce -39.96%1,091,227
MYGNJohn Griffin 2014-06-30 Sold Out -0.38%$33.1 - $42.21
($37.18)
$ 36.42-2%Sold Out0
MYGNJean-Marie Eveillard 2014-06-30 Sold Out -0.03%$33.1 - $42.21
($37.18)
$ 36.42-2%Sold Out0
MYGNJohn Griffin 2014-03-31 Buy 0.38%$20.79 - $38.17
($30.6)
$ 36.4219%New holding, 1000000 sh.1,000,000
MYGNRichard Snow 2014-03-31 Add0.37%$20.79 - $38.17
($30.6)
$ 36.4219%Add 18.11%1,817,401
MYGNJean-Marie Eveillard 2014-03-31 Buy 0.03%$20.79 - $38.17
($30.6)
$ 36.4219%New holding, 284826 sh.284,826
MYGNThird Avenue Management 2014-03-31 Sold Out -0.13%$20.79 - $38.17
($30.6)
$ 36.4219%Sold Out0
MYGNRichard Snow 2013-12-31 Add1.29%$20.79 - $30.65
($25.36)
$ 36.4244%Add 10989.6%1,538,685
MYGNJoel Greenblatt 2013-12-31 Add0.18%$20.79 - $30.65
($25.36)
$ 36.4244%Add 36.27%1,316,314
MYGNThird Avenue Management 2013-12-31 Buy 0.13%$20.79 - $30.65
($25.36)
$ 36.4244%New holding, 328314 sh.328,314
MYGNRonald Muhlenkamp 2013-12-31 Sold Out -2.3%$20.79 - $30.65
($25.36)
$ 36.4244%Sold Out0
MYGNJoel Greenblatt 2013-09-30 Add0.32%$24.396 - $31.8
($28.51)
$ 36.4228%Add 74.78%965,987
MYGNRichard Snow 2013-09-30 Buy 0.02%$24.396 - $31.8
($28.51)
$ 36.4228%New holding, 13875 sh.13,875
MYGNRonald Muhlenkamp 2013-06-30 Buy 2.7%$24.35 - $34.26
($28.98)
$ 36.4226%New holding, 481900 sh.481,900
MYGNRon Baron 2013-06-30 Sold Out -0.09%$24.35 - $34.26
($28.98)
$ 36.4226%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MYGN Richard Snow 2014-09-301,055,0141.451.4-3.32%
MYGN Joel Greenblatt 2014-09-30869,5311.190.33-22.18%
MYGN Andreas Halvorsen 2014-09-30000Sold Out
MYGN John Burbank 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MYGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
King Gary A.Exec. VP International Ops 2014-11-03Sell6,568$39.95-12.77view
Evans James SCFO 2014-09-30Sell21,850$38.99-10.62view
Evans James SCFO 2014-09-24Sell8,790$37.98-8.24view
Evans James SCFO 2014-09-23Sell110,463$37.89-8.02view
LANCHBURY JERRY SChief Scientific Officer 2014-07-14Sell20,000$39.85-12.55view
MELDRUM PETER DPresident & C.E.O. 2014-07-14Sell24,000$39.5-11.77view
HENDERSON JOHN TDirector 2014-06-05Sell5,000$35.7-2.38view
Rogers Ronald S.Exec VP Corp Communications 2014-05-09Sell12,500$36.01-3.22view
MARSH RICHARD ME.V.P., General Counsel 2014-04-30Sell30,000$41.8-16.63view
MARSH RICHARD ME.V.P., General Counsel 2014-04-23Sell31,516$39.8-12.44view

Press Releases about MYGN :

    Quarterly/Annual Reports about MYGN:

    News about MYGN:

    Articles On GuruFocus.com
    Chuck Royce Comments on Myriad Genetics Oct 08 2014 
    Chuck Royce’s Royce Premier Fund Second Quarter 2014 Manager Commentary Oct 08 2014 
    Why I Bought Myriad Genetics (MYGN) Apr 28 2014 
    Scott Black, Delphi Management Recommends Stocks Nov 19 2013 
    Surfing for Billionaire Bargains Sep 22 2013 
    Baron Funds Comments on Myriad Genetics Inc. Jun 06 2013 
    RS Investments' Value Fund First Quarter 2012 Mutual Fund Commentary Apr 17 2012 
    Chuck Royce Buys Hawkins Inc., Myriad Genetics, and Fairchild Semiconductor Jul 07 2011 
    Myriad Genetics Inc. Reports Operating Results (10-Q) May 05 2010 
    Myriad Genetics Inc. (MYGN) CFO James S Evans sells 8,400 Shares Mar 12 2010 


    More From Other Websites
    Myriad, Omaha Steaks, Abbott Healthcare: Intellectual Property Dec 18 2014
    Myriad Loses Appeals Court Bid to Block Breast Cancer Tests Dec 17 2014
    Myriad Genetics Unveils Positive Cancer Study Results Dec 10 2014
    Three New Myriad Studies Highlighted at 2014 San Antonio Breast Cancer Symposium Dec 09 2014
    Three New Myriad Studies Highlighted at 2014 San Antonio Breast Cancer Symposium Dec 09 2014
    MYRIAD GENETICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Dec 05 2014
    Myriad to Present Eight Studies at 2014 San Antonio Breast Cancer Symposium Dec 03 2014
    Myriad to Present Eight Studies at 2014 San Antonio Breast Cancer Symposium Dec 03 2014
    Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years Dec 02 2014
    Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years Dec 02 2014
    Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test Nov 21 2014
    Myriad's Vectra DA: A Better Indicator for Rheumatoid Arthritis Nov 20 2014
    TESARO and Myriad Announce Companion Diagnostics Collaboration Nov 20 2014
    TESARO and Myriad Announce Companion Diagnostics Collaboration Nov 20 2014
    Crescendo Bioscience Highlights New Clinical Data on Vectra(R) DA at ACR Nov 19 2014
    Crescendo Bioscience Highlights New Clinical Data on Vectra(R) DA at ACR Nov 19 2014
    MYRIAD GENETICS INC Financials Nov 14 2014
    Major averages start the week where they left off…higher… Nov 10 2014
    Crescendo Bioscience to Feature New Data on Vectra(R) DA at 2014 ACR Meeting Nov 10 2014
    Crescendo Bioscience to Feature New Data on Vectra(R) DA at 2014 ACR Meeting Nov 10 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Antoniy
    ReplyAntoniy - 11 months ago
    hs
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK